HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 381,713 | $1,828,000 | 1.56% |
| Cowen Prime Services LLC | 441,918 | $2,117,000 | 0.94% |
| Nantahala Capital Management | 363,622 | $1,742,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 45,221 | $217,000 | 0.04% |
| HighMark Wealth Management LLC | 6,666 | $32,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 10,572 | $51,000 | 0.00% |
| Qube Research & Technologies Ltd | 12,034 | $58,000 | 0.00% |
| Squarepoint Ops LLC | 25,597 | $123,000 | 0.00% |
| Ironwood Financial, llc | 103 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 24 | $0 | 0.00% |